Inevitably, intensive insulin therapy is to be considered for reaching HbA1C targets, as supported by UKPDS, which showed that >60% of type 2 diabetic patients will need insulin within 5 years of diagnosis [4, 14]. Here, INS is linked to type 2 diabetes mellitus.